This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Texas System, University of Houston System. Active years: 2006-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boca Raton, FL (US) (2006)
- Galveston, TX (US) (2017 - 2020)
Company Filing History:
4 out of 5,633 
2 out of 618 
Years Active: 2006-2020
Title: Kathryn A Cunningham: Innovator in 5-HTR Agonist Research
Introduction
Kathryn A Cunningham is a prominent inventor based in Galveston, TX (US). She has made significant contributions to the field of pharmacology, particularly in the development of selective 5-HTR agonist analogs. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches for various conditions.
Latest Patents
One of her latest patents involves novel analogs of the selective 5-HTR agonist WAY163909. This invention relates to the preparation and use of these analogs, which could lead to advancements in treatment options. Additionally, her research has identified how the assembly of the 5-HT2cR with another protein, phosphatase and tensin homologue (PTEN), controls cellular function. She has synthesized a new peptide that interrupts the 5-HT2cR:PTEN complex, resulting in enhanced 5-HT2cR function.
Career Highlights
Cunningham has worked with esteemed institutions such as the University of Texas System and the University of Houston System. Her academic and research endeavors have positioned her as a leader in her field, contributing to the understanding of serotonin receptors and their implications in health.
Collaborations
Throughout her career, Kathryn has collaborated with notable colleagues, including Scott R Gilbertson and Carole Sussman. These partnerships have fostered innovation and have been instrumental in advancing her research.
Conclusion
Kathryn A Cunningham's work in the realm of 5-HTR agonist research exemplifies her dedication to innovation and scientific advancement. Her contributions continue to pave the way for future developments in pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile